ULTAULTA
US • —
$450.98
P/E
16.90
PEG
4.02
FCF Yield
—
Rev Growth YoY
+43.0% YoY
Gross Margin
39.3%
Health Score
8/10
D/E Ratio
0.02
Confidence
MEDIUM
Business Snapshot
The company operates in the beauty retail space, offering cosmetics, skincare, fragrance, and salon services across a national footprint. It holds a dominant position as the largest specialty beauty retailer in the United States, benefiting from a strong loyalty program and extensive brand partnerships. The company generates annual net income of over $1.3 billion with a net margin of 9.4%, placing it in the mid-to-large-cap tier. A defining characteristic is its high return on equity of 44.8%, indicating strong capital efficiency in its retail model.
Financial Health
Gross margin stands at 39.3%, while net margin is 9.4% — no prior-year comparison is provided to assess margin trajectory. The balance sheet is exceptionally conservative, with a debt-to-equity ratio of just 0.02x and a current ratio of 1.41x, indicating ample liquidity and very low leverage...
Risk Assessment
- EARNINGS QUALITY — Earnings growth of 4.2% lags revenue growth of 43% by a wide margin, signalling potential margin pressure or rising costs.
- VALUATION — The PEG ratio of 4.02x is elevated, implying the stock is expensive relative to its earnings growth rate.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- INSIDER SELLING — Insiders recorded 1 sell transaction versus 0 buys in the last 90 days, a net selling pattern that bears watching....
Gross margin stands at 39.3%, while net margin is 9.4% — no prior-year comparison is provided to assess margin trajectory. The balance sheet is exceptionally conservative, with a debt-to-equity ratio of just 0.02x and a current ratio of 1.41x, indicating ample liquidity and very low leverage. Free cash flow data is not available in this dataset, preventing a direct assessment of cash generation. Return on equity of 44.8% is outstanding, reflecting highly effective use of shareholder capital. Overall financial health is strong, with minimal debt providing significant capacity for reinvestment, share buybacks, or special dividends.
- EARNINGS QUALITY — Earnings growth of 4.2% lags revenue growth of 43% by a wide margin, signalling potential margin pressure or rising costs. - VALUATION — The PEG ratio of 4.02x is elevated, implying the stock is expensive relative to its earnings growth rate. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - INSIDER SELLING — Insiders recorded 1 sell transaction versus 0 buys in the last 90 days, a net selling pattern that bears watching.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives